_id
691301b2ccc777a4e85d7949
Ticker
INBX
Name
Inhibrx Biosciences, Inc.
Exchange
NASDAQ
Address
11025 North Torrey Pines Road, La Jolla, CA, United States, 92037
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://inhibrx.com
Description
Inhibrx Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of biologic therapeutics for people with life-threatening conditions. Its therapeutic candidates include INBRX-109, a tetravalent therapeutic candidate targeting death-receptor 5 to treat unresectable or metastatic conventional chondrosarcoma; and INBRX-106, a hexavalent sdAb-based therapeutic candidate targeting OX4 for the treatment of metastatic solid tumor, non-small cell lung cancer, melanoma, head and neck squamous cell carcinoma, gastric or gastroesophageal junction adenocarcinoma, renal cell carcinoma, and urothelial cell carcinoma. Inhibrx Biosciences, Inc. was incorporated in 2024 and is based in La Jolla, California.
Last Close
79.44
Volume
280848
Current Price
75.0564
Change
-3.96
Last Updated
2026-01-04T15:12:40.969Z
Image
-
Ipo Date
2024-05-29T00:00:00.000Z
Market Cap
486855008
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.869
Sentiment Sources
1
Rating
3
Strong Buy
0
Buy
0
Hold
1
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
0
Cost Of Revenue
582000
Gross Profit
-582000
Operating Expenses
33229999
Operating Income
-33812000
Interest Expense
3181000
Pretax Income
-35256000
Net Income
-35256000
Eps
-2.2778136710169274
Dividends Per Share
-
Shares Outstanding
14485421
Income Tax Expense
-
EBITDA
-31493000
Operating Margin
-
Total Other Income Expense Net
-1444000
Cash
153088000
Short Term Investments
-
Receivables
837000
Inventories
-
Total Current Assets
161423000
Property Plant Equipment
10310000
Total Assets
177471000
Payables
6773000
Short Term Debt
2247000
Long Term Debt
99917000
Total Liabilities
140641000
Equity
36830000
Bs_currency_symbol
USD
Depreciation
583000
Change In Working Capital
-3423000
Cash From Operations
-33824000
Capital Expenditures
10000
Cash From Investing
-7000
Cash From Financing
352000
Net Change In Cash
-33479000
Cf_currency_symbol
USD
PE
-
PB
31.54284439858811
ROE
-95.7263100733098
ROA
-19.865780888145103
FCF
-33834000
Fcf Percent
-
Piotroski FScore
1
Health Score
17
Deep Value Investing Score
2.5
Defensive Investing Score
5
Dividend Investing Score
1
Economic Moat Investing Score
3.8
Garp Investing Score
1
Growth Investing Score
1
Momentum Investing Score
3.5
Net Net Investing Score
1.5
Quality Investing Score
1
Value Investing Score
1.5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
582000
Quarters > 0 > income Statement > gross Profit
-582000
Quarters > 0 > income Statement > operating Expenses
33229999
Quarters > 0 > income Statement > operating Income
-33812000
Quarters > 0 > income Statement > interest Expense
3181000
Quarters > 0 > income Statement > pretax Income
-35256000
Quarters > 0 > income Statement > net Income
-35256000
Quarters > 0 > income Statement > eps
-2.2778136710169274
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
15478000
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-31493000
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
-1444000
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
153088000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
837000
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
161423000
Quarters > 0 > balance Sheet > property Plant Equipment
10310000
Quarters > 0 > balance Sheet > total Assets
177471000
Quarters > 0 > balance Sheet > payables
6773000
Quarters > 0 > balance Sheet > short Term Debt
2247000
Quarters > 0 > balance Sheet > long Term Debt
99917000
Quarters > 0 > balance Sheet > total Liabilities
140641000
Quarters > 0 > balance Sheet > equity
36830000
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-35256000
Quarters > 0 > cash Flow > depreciation
583000
Quarters > 0 > cash Flow > change In Working Capital
-3423000
Quarters > 0 > cash Flow > cash From Operations
-33824000
Quarters > 0 > cash Flow > capital Expenditures
10000
Quarters > 0 > cash Flow > cash From Investing
-7000
Quarters > 0 > cash Flow > cash From Financing
352000
Quarters > 0 > cash Flow > net Change In Cash
-33479000
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-2.2778136710169274
Quarters > 0 > ratios > PB
31.54284439858811
Quarters > 0 > ratios > ROE
-95.7263100733098
Quarters > 0 > ratios > ROA
-19.865780888145103
Quarters > 0 > ratios > FCF
-33834000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
17
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
1300000
Quarters > 1 > income Statement > cost Of Revenue
662000
Quarters > 1 > income Statement > gross Profit
638000
Quarters > 1 > income Statement > operating Expenses
28027000
Quarters > 1 > income Statement > operating Income
-27389000
Quarters > 1 > income Statement > interest Expense
3141000
Quarters > 1 > income Statement > pretax Income
-28652000
Quarters > 1 > income Statement > net Income
-28654000
Quarters > 1 > income Statement > eps
-1.852469614688389
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
15468000
Quarters > 1 > income Statement > income Tax Expense
2000
Quarters > 1 > income Statement > EBITDA
-24850000
Quarters > 1 > income Statement > operating Margin
-2106.846153846154
Quarters > 1 > income Statement > total Other Income Expense Net
-1263000
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
186567000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
967000
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
193964000
Quarters > 1 > balance Sheet > property Plant Equipment
11345000
Quarters > 1 > balance Sheet > total Assets
212118000
Quarters > 1 > balance Sheet > payables
8292000
Quarters > 1 > balance Sheet > short Term Debt
2169000
Quarters > 1 > balance Sheet > long Term Debt
99279000
Quarters > 1 > balance Sheet > total Liabilities
143559000
Quarters > 1 > balance Sheet > equity
68559000
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-28654000
Quarters > 1 > cash Flow > depreciation
661000
Quarters > 1 > cash Flow > change In Working Capital
-5800000
Quarters > 1 > cash Flow > cash From Operations
-29953000
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
0
Quarters > 1 > cash Flow > net Change In Cash
-29953000
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-1.852469614688389
Quarters > 1 > ratios > PB
16.93391670240231
Quarters > 1 > ratios > ROE
-41.79465861520734
Quarters > 1 > ratios > ROA
-13.50851884328534
Quarters > 1 > ratios > FCF
-29953000
Quarters > 1 > ratios > Piotroski FScore
0
Quarters > 1 > ratios > fcf Percent
-23.040769230769232
Quarters > 1 > health Score
12
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
675000
Quarters > 2 > income Statement > gross Profit
-675000
Quarters > 2 > income Statement > operating Expenses
42226000
Quarters > 2 > income Statement > operating Income
-42901000
Quarters > 2 > income Statement > interest Expense
2689000
Quarters > 2 > income Statement > pretax Income
-43311000
Quarters > 2 > income Statement > net Income
-43311000
Quarters > 2 > income Statement > eps
-2.8000387897595034
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
15468000
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-39947000
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
-410000
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
216520000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
214000
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
223386000
Quarters > 2 > balance Sheet > property Plant Equipment
12450000
Quarters > 2 > balance Sheet > total Assets
242639000
Quarters > 2 > balance Sheet > payables
8892000
Quarters > 2 > balance Sheet > short Term Debt
1973000
Quarters > 2 > balance Sheet > long Term Debt
98653000
Quarters > 2 > balance Sheet > total Liabilities
148196000
Quarters > 2 > balance Sheet > equity
94443000
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-43311000
Quarters > 2 > cash Flow > depreciation
675000
Quarters > 2 > cash Flow > change In Working Capital
3324000
Quarters > 2 > cash Flow > cash From Operations
-35895000
Quarters > 2 > cash Flow > capital Expenditures
21000
Quarters > 2 > cash Flow > cash From Investing
-21000
Quarters > 2 > cash Flow > cash From Financing
99840000
Quarters > 2 > cash Flow > net Change In Cash
63924000
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-2.8000387897595034
Quarters > 2 > ratios > PB
12.292836898446682
Quarters > 2 > ratios > ROE
-45.85940726152282
Quarters > 2 > ratios > ROA
-17.84997465370365
Quarters > 2 > ratios > FCF
-35916000
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
25
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
100000
Quarters > 3 > income Statement > cost Of Revenue
689000
Quarters > 3 > income Statement > gross Profit
-589000
Quarters > 3 > income Statement > operating Expenses
49339000
Quarters > 3 > income Statement > operating Income
-49928000
Quarters > 3 > income Statement > interest Expense
0
Quarters > 3 > income Statement > pretax Income
-47865000
Quarters > 3 > income Statement > net Income
-47865000
Quarters > 3 > income Statement > eps
-3.3065292502630577
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
14475904
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-47176000
Quarters > 3 > income Statement > operating Margin
-49928
Quarters > 3 > income Statement > total Other Income Expense Net
2063000
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
152596000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
420000
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
160398000
Quarters > 3 > balance Sheet > property Plant Equipment
13538000
Quarters > 3 > balance Sheet > total Assets
180767000
Quarters > 3 > balance Sheet > payables
9245000
Quarters > 3 > balance Sheet > short Term Debt
1595000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
47183000
Quarters > 3 > balance Sheet > equity
133584000
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-47865000
Quarters > 3 > cash Flow > depreciation
689000
Quarters > 3 > cash Flow > change In Working Capital
4000
Quarters > 3 > cash Flow > cash From Operations
-43720000
Quarters > 3 > cash Flow > capital Expenditures
16000
Quarters > 3 > cash Flow > cash From Investing
-16000
Quarters > 3 > cash Flow > cash From Financing
0
Quarters > 3 > cash Flow > net Change In Cash
-43736000
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-3.3065292502630577
Quarters > 3 > ratios > PB
8.133528274236436
Quarters > 3 > ratios > ROE
-35.831386992454185
Quarters > 3 > ratios > ROA
-26.478837398418957
Quarters > 3 > ratios > FCF
-43736000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-437.36
Quarters > 3 > health Score
27
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
200000
Annuals > 0 > income Statement > cost Of Revenue
2285000
Annuals > 0 > income Statement > gross Profit
-2085000
Annuals > 0 > income Statement > operating Expenses
329363000
Annuals > 0 > income Statement > operating Income
-331448000
Annuals > 0 > income Statement > interest Expense
13491000
Annuals > 0 > income Statement > pretax Income
1687574000
Annuals > 0 > income Statement > net Income
1687572000
Annuals > 0 > income Statement > eps
116.578004385771
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
14475904
Annuals > 0 > income Statement > income Tax Expense
2000
Annuals > 0 > income Statement > EBITDA
1703350000
Annuals > 0 > income Statement > operating Margin
-165724
Annuals > 0 > income Statement > total Other Income Expense Net
2019022000
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
152596000
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
420000
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
160398000
Annuals > 0 > balance Sheet > property Plant Equipment
13538000
Annuals > 0 > balance Sheet > total Assets
180767000
Annuals > 0 > balance Sheet > payables
9245000
Annuals > 0 > balance Sheet > short Term Debt
1595000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
47183000
Annuals > 0 > balance Sheet > equity
133584000
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
1687572000
Annuals > 0 > cash Flow > depreciation
2285000
Annuals > 0 > cash Flow > change In Working Capital
52051000
Annuals > 0 > cash Flow > cash From Operations
-194409000
Annuals > 0 > cash Flow > capital Expenditures
2597000
Annuals > 0 > cash Flow > cash From Investing
-2597000
Annuals > 0 > cash Flow > cash From Financing
71678000
Annuals > 0 > cash Flow > net Change In Cash
-125328000
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
116.578004385771
Annuals > 0 > ratios > PB
8.13175107917116
Annuals > 0 > ratios > ROE
1263.303988501617
Annuals > 0 > ratios > ROA
933.5619886373065
Annuals > 0 > ratios > FCF
-197006000
Annuals > 0 > ratios > Piotroski FScore
2
Annuals > 0 > ratios > fcf Percent
-985.03
Annuals > 0 > health Score
53
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
1800000
Annuals > 1 > income Statement > cost Of Revenue
1191000
Annuals > 1 > income Statement > gross Profit
609000
Annuals > 1 > income Statement > operating Expenses
219830000
Annuals > 1 > income Statement > operating Income
-219221000
Annuals > 1 > income Statement > interest Expense
31840000
Annuals > 1 > income Statement > pretax Income
-239724000
Annuals > 1 > income Statement > net Income
-241361000
Annuals > 1 > income Statement > eps
-5.121175472098451
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
47130000
Annuals > 1 > income Statement > income Tax Expense
3000
Annuals > 1 > income Statement > EBITDA
-206693000
Annuals > 1 > income Statement > operating Margin
-12178.944444444443
Annuals > 1 > income Statement > total Other Income Expense Net
-20503000
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
277924000
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
778000
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
295358000
Annuals > 1 > balance Sheet > property Plant Equipment
9371000
Annuals > 1 > balance Sheet > total Assets
307893000
Annuals > 1 > balance Sheet > payables
10954000
Annuals > 1 > balance Sheet > short Term Debt
2063000
Annuals > 1 > balance Sheet > long Term Debt
206968000
Annuals > 1 > balance Sheet > total Liabilities
264390000
Annuals > 1 > balance Sheet > equity
43503000
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-239727000
Annuals > 1 > cash Flow > depreciation
1191000
Annuals > 1 > cash Flow > change In Working Capital
15348000
Annuals > 1 > cash Flow > cash From Operations
-193309000
Annuals > 1 > cash Flow > capital Expenditures
4593000
Annuals > 1 > cash Flow > cash From Investing
-4593000
Annuals > 1 > cash Flow > cash From Financing
201961000
Annuals > 1 > cash Flow > net Change In Cash
4059000
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-5.121175472098451
Annuals > 1 > ratios > PB
81.29635197572583
Annuals > 1 > ratios > ROE
-554.8146104866331
Annuals > 1 > ratios > ROA
-78.39119434348946
Annuals > 1 > ratios > FCF
-197902000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-109.94555555555556
Annuals > 1 > health Score
8
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
2192000
Annuals > 2 > income Statement > cost Of Revenue
110186000
Annuals > 2 > income Statement > gross Profit
-107994000
Annuals > 2 > income Statement > operating Expenses
21122000
Annuals > 2 > income Statement > operating Income
-129117000
Annuals > 2 > income Statement > interest Expense
16107000
Annuals > 2 > income Statement > pretax Income
-145223000
Annuals > 2 > income Statement > net Income
-145226000
Annuals > 2 > income Statement > eps
-3.6208736411688442
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
40108000
Annuals > 2 > income Statement > income Tax Expense
3000
Annuals > 2 > income Statement > EBITDA
-125817000
Annuals > 2 > income Statement > operating Margin
-5890.374087591241
Annuals > 2 > income Statement > total Other Income Expense Net
-16106000
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
273865000
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
257000
Annuals > 2 > balance Sheet > inventories
-257000
Annuals > 2 > balance Sheet > total Current Assets
280493000
Annuals > 2 > balance Sheet > property Plant Equipment
7218000
Annuals > 2 > balance Sheet > total Assets
290875000
Annuals > 2 > balance Sheet > payables
8326000
Annuals > 2 > balance Sheet > short Term Debt
1860000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
232818000
Annuals > 2 > balance Sheet > equity
58057000
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-145226000
Annuals > 2 > cash Flow > depreciation
1225000
Annuals > 2 > cash Flow > change In Working Capital
3162000
Annuals > 2 > cash Flow > cash From Operations
-115301000
Annuals > 2 > cash Flow > capital Expenditures
686000
Annuals > 2 > cash Flow > cash From Investing
-686000
Annuals > 2 > cash Flow > cash From Financing
258551000
Annuals > 2 > cash Flow > net Change In Cash
142564000
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-3.6208736411688442
Annuals > 2 > ratios > PB
51.84050708786193
Annuals > 2 > ratios > ROE
-250.1438241727957
Annuals > 2 > ratios > ROA
-49.927288354104
Annuals > 2 > ratios > FCF
-115987000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-52.91377737226277
Annuals > 2 > health Score
8
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
7125000
Annuals > 3 > income Statement > cost Of Revenue
2688000
Annuals > 3 > income Statement > gross Profit
4437000
Annuals > 3 > income Statement > operating Expenses
12341000
Annuals > 3 > income Statement > operating Income
-76564000
Annuals > 3 > income Statement > interest Expense
5216000
Annuals > 3 > income Statement > pretax Income
-81766000
Annuals > 3 > income Statement > net Income
-81768000
Annuals > 3 > income Statement > eps
-2.151223362273086
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
38010000
Annuals > 3 > income Statement > income Tax Expense
2000
Annuals > 3 > income Statement > EBITDA
-75369000
Annuals > 3 > income Statement > operating Margin
-1074.582456140351
Annuals > 3 > income Statement > total Other Income Expense Net
-5202000
Annuals > 3 > income Statement > currency_symbol
-
Annuals > 3 > balance Sheet > cash
131301000
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
878000
Annuals > 3 > balance Sheet > inventories
-878000
Annuals > 3 > balance Sheet > total Current Assets
139112000
Annuals > 3 > balance Sheet > property Plant Equipment
9491000
Annuals > 3 > balance Sheet > total Assets
150450000
Annuals > 3 > balance Sheet > payables
9125000
Annuals > 3 > balance Sheet > short Term Debt
1674000
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
98067000
Annuals > 3 > balance Sheet > equity
52383000
Annuals > 3 > balance Sheet > currency_symbol
-
Annuals > 3 > cash Flow > net Income
-81768000
Annuals > 3 > cash Flow > depreciation
1195000
Annuals > 3 > cash Flow > change In Working Capital
-17516000
Annuals > 3 > cash Flow > cash From Operations
-80323000
Annuals > 3 > cash Flow > capital Expenditures
864000
Annuals > 3 > cash Flow > cash From Investing
-809000
Annuals > 3 > cash Flow > cash From Financing
83769000
Annuals > 3 > cash Flow > net Change In Cash
2637000
Annuals > 3 > cash Flow > currency_symbol
-
Annuals > 3 > ratios > PE
-2.151223362273086
Annuals > 3 > ratios > PB
54.45030639711357
Annuals > 3 > ratios > ROE
-156.09644350266308
Annuals > 3 > ratios > ROA
-54.34895314057826
Annuals > 3 > ratios > FCF
-81187000
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-11.394666666666666
Annuals > 3 > health Score
16
Valuation > metrics > PE
-2.2778136710169274
Valuation > metrics > PB
31.54284439858811
Valuation > final Score
20
Valuation > verdict
951.4% Overvalued
Profitability > metrics > ROE
-95.7263100733098
Profitability > metrics > ROA
-21.84075379592747
Profitability > final Score
15
Profitability > verdict
Weak
Risk > metrics > Debt Equity
3.818653271789302
Risk > metrics > Interest Coverage
-10.62936183590066
Risk > final Score
-37
Risk > verdict
High
Liquidity > metrics > Current Ratio
17.89611973392461
Liquidity > metrics > Quick Ratio
17.89611973392461
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
20
Prev Valuations > 1
20
Prev Valuations > 2
20
Prev Profitabilities > 0
0
Prev Profitabilities > 1
15
Prev Profitabilities > 2
0
Prev Risks > 0
-17
Prev Risks > 1
-34
Prev Risks > 2
-230
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T22:01:58.084Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-11-14
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-2.28
Earnings History > 0 > eps Estimate
-1.57
Earnings History > 0 > eps Difference
-0.71
Earnings History > 0 > surprise Percent
-45.2229
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-08-13
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-1.85
Earnings History > 1 > eps Estimate
-1.55
Earnings History > 1 > eps Difference
-0.3
Earnings History > 1 > surprise Percent
-19.3548
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-05-14
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-2.8
Earnings History > 2 > eps Estimate
-1.41
Earnings History > 2 > eps Difference
-1.39
Earnings History > 2 > surprise Percent
-98.5816
Earnings History > 3 > period
2024-12-31
Earnings History > 3 > report Date
2025-03-17
Earnings History > 3 > date
2024-12-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
-3.09
Earnings History > 3 > eps Estimate
-1.44
Earnings History > 3 > eps Difference
-1.65
Earnings History > 3 > surprise Percent
-114.5833
Earnings History > 4 > period
2024-09-30
Earnings History > 4 > report Date
2024-11-14
Earnings History > 4 > date
2024-09-30
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
-
Earnings History > 4 > eps Actual
-2.84
Earnings History > 4 > eps Estimate
-1.48
Earnings History > 4 > eps Difference
-1.36
Earnings History > 4 > surprise Percent
-91.8919
Earnings History > 5 > period
2024-06-30
Earnings History > 5 > report Date
2024-08-13
Earnings History > 5 > date
2024-06-30
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
-
Earnings History > 5 > eps Actual
125.48
Earnings History > 5 > eps Estimate
-1.52
Earnings History > 5 > eps Difference
127
Earnings History > 5 > surprise Percent
8355.2632
Earnings History > 6 > period
2024-03-31
Earnings History > 6 > report Date
2024-05-29
Earnings History > 6 > date
2024-03-31
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
-
Earnings History > 6 > eps Actual
-1.44
Earnings History > 6 > eps Estimate
-1.04
Earnings History > 6 > eps Difference
-0.4
Earnings History > 6 > surprise Percent
-38.4615
Inhibrx Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of biologic therapeutics for people with life-threatening conditions. Its therapeutic candidates include INBRX-109, a tetravalent therapeutic candidate targeting death-receptor 5 to treat unresectable or metastatic conventional chondrosarcoma; and INBRX-106, a hexavalent sdAb-based therapeutic candidate targeting OX4 for the treatment of metastatic solid tumor, non-small cell lung cancer, melanoma, head and neck squamous cell carcinoma, gastric or gastroesophageal junction adenocarcinoma, renal cell carcinoma, and urothelial cell carcinoma. Inhibrx Biosciences, Inc. was incorporated in 2024 and is based in La Jolla, California.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AShort Interest in Inhibrx Biosciences, Inc. (NASDAQ:INBX) Rises By 63.1% MarketBeat
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
HOLD
$
Analyst Picks
Strong Buy
0
Buy
0
Hold
1
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Very Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Inhibrx Biosciences, Inc.
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
-2.28
EPS Estimate
-1.57
EPS Difference
-0.71
Surprise Percent
-45.2229%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.